Luteolin 6-C-glucoside 8-C-arabinoside

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 黄酮类化合物
• 英文名称: Luteolin 6-C-glucoside 8-C-arabinoside
• 英文别名: 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6,8-bis[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
• 化学式: C₂₇H₃₀O₁₆
• 分子量: 610.5
• InChiKey: ZLPSOQFIIQIIAX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.6
• 重原子数：
  43
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  288
• 氢给体数：
  12
• 氢受体数：
  16

文献信息

• Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
  申请人：AKER BIOMARINE ANTARCTIC AS

  公开号：US10028968B2

  公开（公告）日：2018-07-24

  A phospholipid extract from a marine or aquatic biomass possesses therapeutic properties. The phospholipid extract comprises a variety of phospholipids, fatty acid, metals and a novel flavonoid.

  从海洋或水生生物质中提取的磷脂具有治疗特性。磷脂提取物由多种磷脂、脂肪酸、金属和一种新型黄酮类化合物组成。
• Concentrated therapeutic phospholipid compositions
  申请人：ACASTI PHARMA INC.

  公开号：US10617702B2

  公开（公告）日：2020-04-14

  The invention relates to concentrated therapeutic phospholipid compositions; methods for treating or preventing diseases associated with cardiovascular disease, metabolic syndrome, inflammation and diseases associated therewith, neurodevelopmental diseases, and neurodegenerative diseases, comprising administering an effective amount of a concentrated therapeutic phospholipid composition.

  本发明涉及浓缩治疗性磷脂组合物；治疗或预防与心血管疾病、代谢综合征、炎症及其相关疾病、神经发育疾病和神经退行性疾病有关的疾病的方法，包括施用有效量的浓缩治疗性磷脂组合物。
• CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS
  申请人：Acasti Pharma, Inc.

  公开号：EP2493478B1

  公开（公告）日：2018-02-21
• NATURAL MARINE SOURCE PHOSPHOLIPIDS COMPRISING POLYUNSATURATED FATTY ACIDS AND THEIR APPLICATIONS
  申请人：Sampalis Fotini

  公开号：US20120028922A1

  公开（公告）日：2012-02-02

  A phospholipid extract from a marine or aquatic biomass possesses therapeutic properties. The phospholipid extract comprises a variety of phospholipids, fatty acid, metals and a novel flavonoid.
• US8030348B2
  申请人：——

  公开号：US8030348B2

  公开（公告）日：2011-10-04